DeutschNewstral
Article
bizjournals.com on 2020-09-28 20:10
FSD Pharma gets FDA approval to begin mid-stage testing of potential Covid-19 therapy
Related news
- New Jersey's Antares Pharma receives FDA approval for therapy product after lengthy reviewbizjournals.com
- Durham pharma receives FDA approvalbizjournals.com
- Bucks County biotech gets FDA approval to begin mid-stage testing of experimental Covid-19 therapybizjournals.com
Clinuvel Pharma jumps 47pc on FDA approvalSydney Morning Herald- Jacksonville pharma company gets FDA approvalbizjournals.com
Groundbreaking Penn Cancer Therapy Gets FDA Approvalphillymag.com
Israeli-founded Kite Pharma gets FDA nod for cancer therapytimesofisrael.com- Louisville pharma company gets FDA approval for hemophilia drugbizjournals.com
- Raleigh pharma gets FDA approval to explore Covid-19 treatmentbizjournals.com
- MHookipa Pharma jumps 40% after FDA approval of clinical testsmarketwatch.com
- MEyePoint Pharma shares jump on FDA approval of Yutiq implantmarketwatch.com
- West Chester pharma firm seeks FDA approval for new drugbizjournals.com
- United Therapeutics gets another FDA approval for pulmonary hypertension therapybizjournals.com
FDA Receives Application for Approval of MDMA-Assisted Therapyjdsupra.com
FDA Soon Rules If First CRISPR Therapy Receives Commercial ApprovalForbes- Immunocore gets FDA approval for cell therapy targeting melanomabizjournals.com
- Breakthrough cancer therapy developed at Penn receives 2nd FDA approvalbizjournals.com
$3.5M gene therapy for hemophilia gets FDA approvalseattletimes.com